Compara mètodes
Revisa els mètodes seleccionats l'un al costat de l'altre; les files que difereixen es ressalten.
| Revisió paraigua compliant amb PRISMA× | Metaanàlisi en xarxa× | |
|---|---|---|
| Camp≠ | Cienciometria | Síntesi d'evidència |
| Família | Process / pipeline | Process / pipeline |
| Any d'origen≠ | 2015 (umbrella review methodology); 2022 (PRIOR reporting extension) | 2002 |
| Autor original≠ | Aromataris et al. (JBI); PRIOR reporting extension by Fusar-Poli et al. | Lumley (2002) |
| Tipus≠ | Evidence synthesis / review of systematic reviews | Method |
| Font seminal≠ | Aromataris, E., Fernandez, R., Godfrey, C. M., Holly, C., Khalil, H., & Tungpunkom, P. (2015). Summarizing systematic reviews: Methodological development, conduct and reporting of an umbrella review approach. International Journal of Evidence-Based Healthcare, 13(3), 132–140. DOI ↗ | Lumley, T. (2002). Network meta-analysis for indirect treatment comparisons. Statistics in Medicine, 21(16), 2313–2324. DOI ↗ |
| Àlies≠ | umbrella review with PRISMA, PRIOR-guided umbrella review, overview of reviews, PRISMA umbrella overview | Mixed Treatment Comparison, MTC, Indirect Comparison Meta-Analysis |
| Relacionats≠ | 5 | 1 |
| Resum≠ | A PRISMA-compliant umbrella review is a structured synthesis of existing systematic reviews and meta-analyses on a topic, conducted and reported in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines — specifically the PRIOR extension developed for umbrella reviews. By operating one level above primary research, it maps the totality of evidence, identifies convergent or contradictory findings across reviews, and quantifies evidence strength at the highest tier of the evidence hierarchy. | Network meta-analysis (NMA) is a systematic method for comparing multiple interventions simultaneously within a single analytical framework, incorporating both direct evidence (head-to-head trials) and indirect evidence (comparisons via common comparators). First formalized by Lumley in 2002, NMA allows researchers to rank treatments and quantify comparative effectiveness even when some treatment pairs have never been directly studied. |
| ScholarGateConjunt de dades ↗ |
|
|